Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

[Branch duct IPMN: resection or surveillance?]

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):74. doi: 10.1007/s00104-019-0871-y. German. No abstract available.

PMID:
30758560
2.

[Branch duct intraductal papillary mucinous neoplasm - surgical approach].

Kaiser J, Büchler MW, Hackert T.

Chirurg. 2017 Nov;88(11):927-933. doi: 10.1007/s00104-017-0491-3. Review. German.

PMID:
28801818
3.

Main- and Branch-Duct Intraductal Papillary Mucinous Neoplasms: Extent of Surgical Resection.

Hackert T, Fritz S, Büchler MW.

Viszeralmedizin. 2015 Feb;31(1):38-42. doi: 10.1159/000375111. Review.

4.

Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas.

Bournet B, Kirzin S, Carrère N, Portier G, Otal P, Selves J, Musso C, Suc B, Moreau J, Fourtanier G, Pradère B, Lazorthes F, Escourrou J, Buscail L.

J Gastroenterol Hepatol. 2009 Jul;24(7):1211-7. doi: 10.1111/j.1440-1746.2009.05826.x. Epub 2009 May 19.

PMID:
19476563
5.

Invasive carcinoma derived from branch duct-type IPMN may be a more aggressive neoplasm than that derived from main duct-type IPMN.

Okabayashi T, Shima Y, Kosaki T, Sumiyoshi T, Kozuki A, Iiyama T, Takezaki Y, Kobayashi M, Nishimori I, Ogawa Y, Hanazaki K.

Oncol Lett. 2013 Jun;5(6):1819-1825. Epub 2013 Mar 21.

6.

Size of mural nodule as an indicator of surgery for branch duct intraductal papillary mucinous neoplasm of the pancreas during follow-up.

Uehara H, Ishikawa O, Katayama K, Kawada N, Ikezawa K, Fukutake N, Takakura R, Takano Y, Tanaka S, Takenaka A.

J Gastroenterol. 2011 May;46(5):657-63. doi: 10.1007/s00535-010-0343-0. Epub 2010 Nov 18.

PMID:
21085997
7.

[Branch duct intraductal papillary mucinous neoplasm - contra resection].

Brunner M, Weber GF, Kersting S, Grützmann R.

Chirurg. 2017 Nov;88(11):918-926. doi: 10.1007/s00104-017-0495-z. Review. German.

PMID:
28871376
8.

The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.

Hirono S, Tani M, Kawai M, Okada K, Miyazawa M, Shimizu A, Kitahata Y, Yamaue H.

Ann Surg. 2012 Mar;255(3):517-22. doi: 10.1097/SLA.0b013e3182444231.

PMID:
22301608
9.

A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.

Yan L, Siddiqui AA, Laique SN, Saumoy M, Kahaleh M, Yoo J, Kalra A, Mathew A, Sterling J, Rao R, Lieberman M, Cosgrove N, Sharaiha RZ.

Minerva Gastroenterol Dietol. 2017 Mar;63(1):50-54. doi: 10.23736/S1121-421X.16.02341-2. Epub 2016 Nov 8.

PMID:
27824244
10.

Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.

Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K.

J Clin Gastroenterol. 2006 Oct;40(9):856-62.

PMID:
17016145
11.

Obesity increases malignant risk in patients with branch-duct intraductal papillary mucinous neoplasm.

Sturm EC, Roch AM, Shaffer KM, Schmidt CM 2nd, Lee SJ, Zyromski NJ, Pitt HA, Dewitt JM, Al-Haddad MA, Waters JA, Schmidt CM.

Surgery. 2013 Oct;154(4):803-8; discussion 808-9. doi: 10.1016/j.surg.2013.07.011.

PMID:
24074418
12.
13.

Lateral spread along the main pancreatic duct in branch-duct intraductal papillary-mucinous neoplasms of the pancreas: usefulness of intraductal ultrasonography for its evaluation.

Kobayashi G, Fujita N, Noda Y, Ito K, Horaguchi J, Obana T, Koshida S, Kanno Y, Yamashita Y, Kato Y, Ogawa T, Sawai T.

Dig Endosc. 2011 Jan;23(1):62-8. doi: 10.1111/j.1443-1661.2010.01063.x.

PMID:
21198919
14.

Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.

Uehara H, Nakaizumi A, Ishikawa O, Iishi H, Tatsumi K, Takakura R, Ishida T, Takano Y, Tanaka S, Takenaka A.

Gut. 2008 Nov;57(11):1561-5. doi: 10.1136/gut.2007.145631. Epub 2008 May 13.

PMID:
18477671
15.

Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.

Fritz S, Klauss M, Bergmann F, Strobel O, Schneider L, Werner J, Hackert T, Büchler MW.

Ann Surg. 2014 Nov;260(5):848-55; discussion 855-6. doi: 10.1097/SLA.0000000000000980.

PMID:
25379856
16.

Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.

Schnelldorfer T, Sarr MG, Nagorney DM, Zhang L, Smyrk TC, Qin R, Chari ST, Farnell MB.

Arch Surg. 2008 Jul;143(7):639-46; discussion 646. doi: 10.1001/archsurg.143.7.639.

PMID:
18645105
17.

The natural history of main duct-involved, mixed-type intraductal papillary mucinous neoplasm: parameters predictive of progression.

Roch AM, Ceppa EP, Al-Haddad MA, DeWitt JM, House MG, Zyromski NJ, Nakeeb A, Schmidt CM.

Ann Surg. 2014 Oct;260(4):680-8; discussion 688-90. doi: 10.1097/SLA.0000000000000927.

PMID:
25203885
18.

Intraductal papillary mucinous neoplasm--when to resect?

Waters JA, Schmidt CM.

Adv Surg. 2008;42:87-108. Review.

PMID:
18953811
19.

Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: a radiographic finding with potentially increased malignant potential.

Ammori JB, Do RK, Brennan MF, D'Angelica MI, Dematteo RP, Fong Y, Jarnagin WR, Allen PJ.

J Gastrointest Surg. 2014 May;18(5):911-6. doi: 10.1007/s11605-014-2449-9. Epub 2014 Jan 22.

20.

Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm.

Tang RS, Weinberg B, Dawson DW, Reber H, Hines OJ, Tomlinson JS, Chaudhari V, Raman S, Farrell JJ.

Clin Gastroenterol Hepatol. 2008 Jul;6(7):815-9; quiz 719. doi: 10.1016/j.cgh.2008.04.005.

PMID:
18602036

Supplemental Content

Support Center